Pure Bioscience PURE Cash Flow Statement (2010-2026)

OTC PURE
$0.07 -0.01 (-12.50%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Pure Bioscience Quarterly Cash Flow Statement

Periods 63 quarters
Latest Apr 2026

Pure Bioscience reported cash from operations of -$0.47M and free cash flow of -$0.47M for the quarter ended Apr 2026, up 8.6% year over year. This cash flow statement covers 63 quarters of results from Oct 2010 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Operating Activities
Net Income
-0.73M-0.80M-0.70M-0.76M-1.23M-0.99M-1.06M-0.88M-1.03M-0.74M-1.00M-0.86M-0.76M-0.69M-0.80M-0.58M-0.33M-0.46M-0.79M-0.62M
Depreciation and DepletionDep. & Depletion
0.04M0.04M0.00M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.04M0.06M0.05M0.05M0.05M0.03M0.04M0.04M0.02M0.04M0.04M0.04M0.04M0.00M
Share-based CompensationStock Comp.
0.16M0.19M0.16M0.10M0.07M0.08M0.11M0.04M0.05M0.08M0.06M0.03M0.04M0.06M0.03M0.03M0.03M0.03M0.06M0.06M
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
0.28M
Other non-cash itemsOther Non-Cash
Change in Working Capital
Change in ReceivablesChange Receivables
0.15M-0.13M-0.03M-0.01M0.00M0.05M-0.10M0.03M0.10M0.06M-0.18M0.06M0.06M0.07M-0.19M0.11M0.19M-0.09M-0.14M-0.01M
Change in InventoryChange Inventory
-0.09M-0.02M-0.01M0.00M-0.05M0.06M-0.04M-0.01M-0.07M0.02M-0.03M-0.02M0.02M0.00M0.06M0.01M0.10M0.01M-0.01M
Change in Accured ExpensesChange Accured Exp.
0.03M-0.14M-0.01M-0.03M0.03M0.12M-0.24M0.11M-0.04M0.27M-0.22M0.08M0.07M0.18M-0.05M0.11M0.05M0.12M0.07M0.10M
Change in Other Operating AssetsOther Assets Change
0.00M0.04M-0.04M0.00M-0.01M0.04M-0.03M0.01M0.02M0.04M-0.04M-0.02M-0.02M0.02M-0.02M-0.02M0.01M0.02M-0.03M0.01M
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
0.00M-0.04M0.04M0.00M0.01M-0.04M0.03M-0.01M-0.02M-0.04M0.04M0.02M0.02M-0.02M0.02M0.02M-0.01M-0.02M0.03M-0.01M
Cash from OperationsCash from Ops.
-0.41M-0.58M-0.63M-0.61M-0.60M-0.90M-0.97M-0.67M-0.74M-0.44M-0.88M-0.62M-0.59M-0.50M-0.54M-0.51M-0.46M-0.25M-0.61M-0.47M
Investing Activities
Capital ExpendituresCapex
0.02M0.05M0.00M0.01M0.02M0.04M0.04M-0.04M
Change in Property, Plant and EquipmentChange in PP&E
-0.02M-0.05M0.00M-0.01M-0.02M-0.04M-0.04M0.04M
Change in IntangiblesChange Intangibless
Cash from Investing ActivitiesCash from Investing
-0.02M-0.05M0.00M-0.01M-0.02M-0.04M-0.04M0.04M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.79M0.50M0.50M0.50M0.40M0.85M0.25M0.35M0.37M0.25M
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
0.79M0.50M0.50M0.50M0.40M0.85M0.25M0.35M0.37M0.25M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.79M0.50M0.50M0.50M0.40M0.85M0.25M0.35M0.37M0.25M
Change in Capital Stock
Common Stock IssuedStock Issued
Net Shares Issued and RepurchasedNet Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
Cash from Financing ActivitiesCash from Financing
0.79M0.50M0.50M0.50M0.40M0.85M0.25M0.35M0.37M1.25M
Additional items
Change in Cash
-0.43M-0.63M-0.63M-0.62M2.88M-0.94M-0.97M-0.70M0.31M0.35M-0.88M-0.12M-0.09M0.00M-0.14M0.34M-0.21M0.10M-0.24M0.79M
Ending Cash Balance
2.47M1.84M1.21M0.59M3.47M2.53M1.56M0.86M1.17M1.52M0.63M0.52M0.42M0.42M0.28M0.62M0.41M0.51M0.27M1.06M
Free Cash FlowFCF
-0.43M-0.63M-0.63M-0.62M-0.62M-0.94M-0.97M-0.70M-0.70M-0.44M-0.88M-0.62M-0.59M-0.50M-0.54M-0.51M-0.46M-0.25M-0.61M-0.47M
Net Cash FlowNCF
-0.43M-0.63M-0.63M-0.62M-0.62M-0.94M-0.97M-0.70M-0.70M0.35M-0.88M-0.12M-0.09M0.00M-0.14M0.34M-0.21M0.10M-0.24M0.79M
Interest Paid
Income Taxes PaidTaxes Paid

Pure Bioscience Cash Flow Statement API

Pull Pure Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PURE&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY